Shares of Genus plc (LON:GNS – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 2,628.10 and traded as high as GBX 3,175. Genus shares last traded at GBX 3,135, with a volume of 55,584 shares changing hands.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on the stock. Shore Capital Group restated a “buy” rating and set a GBX 3,000 price objective on shares of Genus in a research report on Friday, January 16th. Berenberg Bank reissued a “buy” rating and issued a GBX 3,350 price target on shares of Genus in a research note on Thursday, February 5th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of Genus from GBX 3,100 to GBX 3,300 and gave the company a “buy” rating in a research report on Friday, January 16th. Three analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of GBX 3,216.67.
Get Our Latest Stock Analysis on Genus
Genus Trading Up 0.5%
About Genus
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
See Also
- Five stocks we like better than Genus
- Unlocked: Elon Musk’s Next Big IPO
- Buy This Stock Now
- America’s 1776 happening again
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
